<DOC>
	<DOCNO>NCT02797717</DOCNO>
	<brief_summary>Reduction indication radiotherapy ( RT ) newly diagnose patient classical Hodgkins lymphoma without compromise cure rate . Investigation chemotherapy intensification randomisation intermediate advance classical Hodgkins lymphoma patient compensate reduction RT .</brief_summary>
	<brief_title>Treatment Classical Hodgkin Lymphoma Children Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>1. histologically confirm primary diagnosis classical Hodgkin 's lymphoma . 2. patient 18 year age date write informed consent . In specialized Teenage Young Adult ( TYA ) unit Australia , France , Italy , New Zealand United Kingdom patient 25 year age also enrol . Lower age limit country specific accord national law formal insurance requirement may preclude young patient . 3. write informed consent patient and/or patient 's parent guardian accord national law . 4. negative pregnancy test within 2 week prior start treatment female patient childbearing potential ( Patients one follow criterion exclude ) 1. prior chemotherapy radiotherapy malignancy 2. pretreatment Hodgkin 's lymphoma ( except steroid prephase maximum 710 day emergency treatment large mediastinal tumour ) . 3. diagnosis lymphocytepredominant Hodgkin 's lymphoma 4. ( simultaneous ) malignancies 5. contraindication know hypersensitivity study drug 6. severe concomitant disease ( e.g . immune deficiency syndrome ) 7. know HIVpositivity 8. residence outside participate country long term followup guarantee 9. pregnancy / lactation 10. patient sexually active unwilling use adequate contraception therapy one month last trial treatment 11. current recent ( within 30 day prior date write informed consent ) treatment another investigational drug participation another interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>